Document:

ex102.htm

HCI VIOCARE TECHNOLOGIES LIMITED

Kintyre House 209 Govan Road,

Glasgow, G51 1 HJ, UK

T: +44 (0)141 3700321

F: +44 (0) 141 3700322

 

 

Christos Kapatos

66 Stewarton Drive

Cambuslang

Glasgow

G72 8DG

 

Dear Christos

 

Amendment of Acquisition Agreement

 

We refer to your recent discussions with us, HCi VioCare Technologies Limited (the “Company”), regarding the acquisition agreement you entered into with the Company dated 17th April 2014 (the “Agreement”).

 

We now write to confirm the terms on which we agree that the Agreement shall be amended.  This letter is deemed to satisfy the requirements of clause 18 of the Agreement and  terms defined in the Agreement shall have the same meaning when used in this letter unless expressly stated otherwise.

Accordingly it is agreed that the Agreement is now amended as follows:

	
1.  

	
The phrase “(the “Consideration Shares”)” is deleted from clause 6.1(i).

 

	
2.  

	
The word “and” is added at the end of clause 6.1(i).

 

	
3.  

	
Clause 6.1(ii) is deleted and replaced with the following:

 

“a total of one million (1,000,000) common shares in the common stock of HCi VioCare, the parent corporation of the Company to the Individual, which shares shall be issued on or around May 11th, 2015 and shall be subject to such restrictions as may be required by the requisite regulatory authorities.”

 

	
4.  

	
The phrase “(“together the “Consideration Shares”)” is added in a new line at the end of clause 6.1.

 

	
5.  

	
Clause 6.2(iii) shall be renumbered as clause 6.2.

 

	
6.  

	
Clause 6.2 (formerly clause 6.2(iii)) shall be amended by deleting the first sentence, being the sentence starting with “a cash bonus” and ending with “(the “Cash Consideration”).”

 

  

1

  

 

	
7.  

	
The definition of Project shall be amended by adding the following at the end of the definition:

 

“together with all underlying technology relating to the ‘Smart Insole’ (including but not limited to mechanisms for the measurement of pressure and shear by use of sensors)  and the application of such technology in all other markets including but not limited to sports, 3D positioning and gait analysis systems, car seats, mattresses and hospital beds.”

 

	
8.  

	
Delete all references to “Additional Consideration Shares” from clause 10.2.3.

 

To the extent the amendment set out at paragraph 7 covers any IPR which has not previously assigned to the Company but which now requires to assign to the Company, all such IPR shall assign automatically to the Company on signature by you of this letter.

 

This letter shall be governed by the laws of Scotland and the Scottish courts shall have the non-exclusive jurisdiction as regards any claim or dispute relating to it.

 

Other than this amendment the terms of the Agreement remain unchanged and in full force and effect.

 

Please sign the duplicate of this letter enclosed and return it to me to indicate your acceptance of its terms.

 

Yours faithfully

 

 

Sotirios Leontaritis

Director

For and on behalf of HCi VioCare Technologies Limited

 

 

I agree to the foregoing terms of this letter

..........................................................

Christos Kapatos

Date:  May 8th, 2015

  

2ex103.htm

Addendum No. 1

Dated May 1, 2015 to that certain consulting agreement originally dated as of the 16th day of April 2014 by and  between  HCi Viocare, a Nevada corporation, with offices at Centrum Offices, 38 Queen Street, Glasgow, UK G1 3DX (the “Company”), and Dr. Christos Kapatos, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the “Consultant”), hereinafter referred to as the “Agreement”.

In accordance with Item 2. – Term; Subsection 2.1 to the Agreement, the Company hereby extends the Term for a period of one year from the date of this Addendum No. 1.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

 

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

 

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

	
 

The Company 

 

 

 

 

 

HCi Viocare

By its President

Sotirios Leontaritis

 

 

	
 

The Consultant

 

 

 

 

 

Dr. Christos Kapatos

	  	  

 

  

1

  

Addendum No. 1

Dated May 1, 2015 to that certain consulting agreement originally dated as of the 16th day of April 2014 by and  between  HCi Viocare, a Nevada corporation, with offices at Centrum Offices, 38 Queen Street, Glasgow, UK G1 3DX (the “Company”), and Professor William Sandham, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the “Consultant”), hereinafter referred to as the “Agreement”.

In accordance with Item 2. – Term; Subsection 2.1 to the Agreement, the Company hereby extends the Term for a period of one year from the date of this Addendum No. 1.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

 

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

 

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

	
 

The Company 

 

 

 

 

HCi Viocare

By its President

Sotirios Leontaritis

 

 

	
 

The Consultant

 

 

 

                 

Professor William Sandham

	  	  

  

2

  

Addendum No. 1

Dated May 1, 2015 to that certain consulting agreement originally dated as of the 16th day of April 2014 by and  between  HCi Viocare, a Nevada corporation, with offices at Centrum Offices, 38 Queen Street, Glasgow, UK G1 3DX (the “Company”), and Professor Stephan Solomonidis, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the “Consultant”), hereinafter referred to as the “Agreement”.

In accordance with Item 2. – Term; Subsection 2.1 to the Agreement, the Company hereby extends the Term for a period of one year from the date of this Addendum No. 1.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

 

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

 

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

	
 

The Company 

 

 

 

 

HCi Viocare

By its President

Sotirios Leontaritis

 

 

	
 

The Consultant

 

 

 

 

Professor Stephan Solomonidis

	  	  

 

  

3ex104.htm

ADDENDUM No. 1

Dated May 1, 2015 to that certain agreement originally dated as of the 15th day of April 2014 by and  between  HCi Viocare (the “Company”) and Professor Stephan Solomonidis, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the “Advisor”), hereinafter referred to as the “Agreement”.

   

This Addendum No. 1 shall serve to remove and replace in its entirety the Section 2. Term; Subsection 2.1 Term to that certain Agreement with the paragraph set out below;

“The term of this Agreement (the “Term”) shall be from and including April 15, 2014, to and including April 15, 2016, unless this Agreement is earlier terminated in accordance with Section 5”.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

   

The Company                                                                                                                                                           The Advisor

 

 

HCi Viocare                                                                                                                                                             Professor Stephan Solomonidis

By its President

Sotirios Leontaritis

 

  

1

  

ADDENDUM No. 1

Dated May 1, 2015 to that certain agreement originally dated as of the 15th day of April 2014 by and  between  HCi Viocare (the “Company”) and Professor William Sandham, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the “Advisor”), hereinafter referred to as the “Agreement”.

   

This Addendum No. 1 shall serve to remove and replace in its entirety the Section 2. Term; Subsection 2.1 Term to that certain Agreement with the paragraph set out below;

“The term of this Agreement (the “Term”) shall be from and including April 15, 2014, to and including April 15, 2016, unless this Agreement is earlier terminated in accordance with Section 5”.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

   

The Company                                                                                                 The Advisor

 

 

HCi Viocare                                                                                                   Professor William Sandham

By its President

Sotirios Leontaritis

 

  

2

  

ADDENDUM No. 1

Dated May 1, 2015 to that certain agreement originally dated as of the 15th day of April 2014 by and  between  HCi Viocare (the “Company”) and Professor Martha Lucia Zequera, resident of Cra 81A #137D-75 Casa 4; Conjunto La Aravcaria; Provenza Suba; Bogota, Colombia (the “Advisor”), hereinafter referred to as the “Agreement”.

   

This Addendum No. 1 shall serve to remove and replace in its entirety the Section 2. Term; Subsection 2.1 Term to that certain Agreement with the paragraph set out below;

“The term of this Agreement (the “Term”) shall be from and including April 15, 2014, to and including April 15, 2016, unless this Agreement is earlier terminated in accordance with Section 5”.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

   

The Company                                                                                                 The Advisor

 

 

HCi Viocare                                                                                                   Professor Martha Lucia Zequera

By its President

Sotirios Leontaritis

 

  

3

  

ADDENDUM No. 1

Dated May 1, 2015 to that certain agreement originally dated as of the 15th day of April l 2014 by and between HCi Viocare, a Nevada corporation, with offices at Centrum  Offices,  38 Queen Street, Glasgow, U K  G I  3DX  (the "Company"), and  Dr.  Christos  Kapatos,  resident  of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, U K (the "Advisor"), hereinafter referred to as the  “Agreement”.

 

This Addendum No. 1 shall serve to remove and replace in its entirety the Section 2. Term; Subsection 2.1 Term to that certain Agreement with the paragraph set out below;

“The term of this Agreement (the “Term”) shall be from and including April 15, 2014, to and including April 15, 2016, unless this Agreement is earlier terminated in accordance with Section 5”.

This Addendum No. 1 shall ensure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).

The terms and conditions and provisions as contained in the Agreement remain in full force and effect.

 

This Addendum No. 1 shall be appended to and form a part of the Agreement.

	
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 1 to be duly executed and delivered as of the day and year first written above.

 

  

  

  

The Company                             The Advisor

  

HCi Viocare                              Dr. Christos Kapatos 

By its President

Sotirios Leontaritis

  

  

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]